These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 956635)

  • 1. [Development of the breasts of the fetus. Effects of the administration of hormonal preparations during pregnancy].
    Vrettos AS; Fotiou S; Papaharalampus N
    J Gynecol Obstet Biol Reprod (Paris); 1976 Jun; 5(4):561-6. PubMed ID: 956635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient parkinsonism: induced by progesterone or pregnancy?
    Demirkiran M; Aslan K; Bicakci S; Bozdemir H; Ozeren A
    Mov Disord; 2004 Nov; 19(11):1382-4. PubMed ID: 15389979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Risks and benefits of hormonal agents in pregnancy.
    Kohrman AF; Jones LA; Bern HA
    N Engl J Med; 1976 Mar; 294(11):614-5. PubMed ID: 942759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum progesterone and estradiol in pregnant women selected for progestagen treatment.
    Dubin NH; Moszkowski EF; Kavoussi KM; Ward MM; Ances IG
    Int J Fertil; 1979; 24(2):86-93. PubMed ID: 40914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and harmlessness of 17-hydroxyprogesterone caproate and estradiol valerate in the preventive treatment of habitual abortion].
    Rosa P
    Gynecol Obstet (Paris); 1967; 66(5):549-68. PubMed ID: 5584581
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of threatened abortion (author's transl)].
    Berle P; Behnke K
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):139-42. PubMed ID: 320090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of habitual abortion with caprovestrol].
    Kovtumova LG; Turbina ZV; Rymashevskaia EP; Zelenkova LT
    Vopr Okhr Materin Det; 1976 May; 21(5):72-5. PubMed ID: 1027289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigation of children exposed to Gestanon during intrauterine life].
    Mladenović D; Grcić R; Kapor M; Pestelek B; Plećas A
    Med Pregl; 1979; 32(9-10):421-5. PubMed ID: 530218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone therapy of threatened abortion].
    Stojanov S
    Zentralbl Gynakol; 1972 Oct; 94(40):1323-6. PubMed ID: 4118064
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex hormones in pregnancy.
    Darling MR; Hawkins DF
    Clin Obstet Gynaecol; 1981 Aug; 8(2):405-19. PubMed ID: 7028351
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gravibinan in the treatment of threatened abortion].
    Krzysiek J; Milewicz S; Paradysz A
    Ginekol Pol; 1976 Mar; 47(3):321-5. PubMed ID: 943363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypospadias induced by hormone therapy?].
    Mellin P
    Dtsch Med Wochenschr; 1970 May; 95(22):1243-4. PubMed ID: 5463881
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of hormone assays and high dose HCG, estrogen and 17-alpha-hydroxyprogesterone treatment in the prevention of threatened abortion due to endocrine causes.
    Cubesi G; Plancher G; Destro F
    Acta Eur Fertil; 1970 Sep; 2(3):355-8. PubMed ID: 5538329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 17-alpha-hydroxy-progesterone capronate on the motility of the human uterus in puerperium following abortion].
    Data PG; Morra C; Lanza A; Scaramuzza P
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):471-6. PubMed ID: 4787512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Threatened abortion: patient characteristics, treatment results and consequences for the child].
    Eggimann UH; Thürig E; Moser H; Bossi E
    Schweiz Med Wochenschr; 1979 Feb; 109(8):288-92. PubMed ID: 571142
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
    Gerhard I; Runnebaum B
    Biol Res Pregnancy Perinatol; 1984; 5(4):157-73. PubMed ID: 6084523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate].
    Tóth F; Kónya Z
    Z Geburtshilfe Gynakol; 1971 Oct; 175(2):168-75. PubMed ID: 5118523
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data.
    Wiseman RA; Dodds-Smith IC
    Teratology; 1984 Dec; 30(3):359-70. PubMed ID: 6240131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 20. [Athelia and amastia with a dysplastic shoulder girdle. Case report].
    Imbach P
    Helv Paediatr Acta; 1971 Apr; 26(1):14-8. PubMed ID: 5577873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.